18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin;18F-FDG PET/TC nella valutazione del tumore primitivo ignoto

Radiologia Medica

Volumn 111, Issue 8, 2006, Pages 1146-1155

  Ambrosini, V ^a   Nanni, C ^a   Rubello, D ^b   Moretti, A ^c   Battista, G ^a   Castellucci, P ^a   Farsad, M ^a   Rampin, L ^b   Fiorentini, G ^c   Franchi, R ^a   Canini, R ^a   Fanti, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale S Maria della Misericordia   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

18F FDG PET CT; Metastatic cancer; Occult primary cancer

Indexed keywords

BIOGRAPH SENSATION 16; DISCOVERY LS; FLUORODEOXYGLUCOSE F 18; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIET RESTRICTION; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CANCER; IMAGE PROCESSING; INTERMETHOD COMPARISON; LARYNX CANCER; LUNG CANCER; MALE; METASTASIS; OCCULT CANCER; OVARY CANCER; PANCREAS CANCER; PATIENT POSITIONING; POSITRON EMISSION TOMOGRAPHY; STANDARD; TESTIS CANCER; THYROID CARCINOMA; TONGUE CANCER; TONSIL CANCER; WHOLE BODY SCANNER; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; METHODOLOGY; MIDDLE AGED; NEOPLASM; PROGNOSIS; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845876587     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-006-0112-6     Document Type: Article

References (15)

1. Abbruzzese J, Abbruzzese M, Lenzi R et al (1995) Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13:2094-2103
2. Le Chevalier T, Cvitkovic E, Caille P et al (1988) Early metastatic cancer of unknown primary origin at presentation. Arch Intern Med 148:2035-2039
3. Didolkar MS, Fanous N, Elias EG, Moore RH (1977) Metastatic carcinoma from occult primary tumors: a study of 254 patients. Ann Surg 186:625-630
4. Steckel RJ, Kagan AR (1980) Diagnostic persistence in working up metastatic cancer with an unknown primary site. Radiology 134:367-369
5. Naresh KN (2002) Do metastatic tumours from an unknown primary reflect angiogenic incompetence of the tumour at the primary site? A hypothesis. Med Hypotheses 59:357-360
6. Ellerbroek N, Holmes F, Singletary E et al (1990) Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 66:1461-1467
7. Raber MN, Faintuch J, Abbruzzese JL et al (1991) Continuous infusion 5-fluorouracil, etoposide and cisplatin in patients with metastatic carcinoma of unknown primary origin. Ann Oncol 2:519-520
8. Syed R, Bomanji JB, Nagabhushan N et al (2005) Impact of combined (18)F-FDG PET/CT in head and neck tumours. Br J Cancer 92:1046-1050
9. Gutzeit A, Antoch G, Kuhl H et al (2005) Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology 234:227-234
10. Freudenberg LS, Fischer M, Antoch G et al (2005) Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract 14:155-160
11. Kole AC, Nieweg OE, Pruim J et al (1998) Detection of unknown occult primary tumors using positron emission tomography. Cancer 82:1160-1166
12. Alberini JL, Belhocine T, Hustinx R et al (2003) Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome). Nucl Med Commun 24:1081-1086
13. Bohuslavizki KH, Klutmann S, Kroger S et al (2000) FDG PET detection of unknown primary tumors. J Nucl Med 41:816-822
14. Cohade C, Wahl RL (2003) Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 33:228-237
15. Kluetz PG, Meltzer CC, Villemagne VL et al (2000) Combined PET/CT Imaging in Oncology. Impact on Patient Management. Clin Positron Imaging. 3:223-230